Leading in the Age of Evidence, genomic diagnostic products #Afirma #Percepta #Envisia #thyroidcancer #lungcancer #IPF
Location: United States, California, South San Francisco
Employees: 501-1000
Total raised: $101M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Kleiner Pe... | kleinerper... |
| - | TPG | tpg.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.03.2016 | - | $45M | - |
| 01.07.2013 | Series C | $28M | - |
| 10.06.2010 | Series B | $28M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 08.01.2024 | Veracyte Acquires C2i Genomics | Veracyte, Inc. (Nasdaq: VCYT), a South San Francisco, CA-based cancer diagnostics company, reached a... | finsmes.co... |
| 05.12.2022 | A Tumor Microenvironment-Based Multiomics Analysis for Predi... | With a growing number of clinical trials testing immune checkpoint inhibitors (ICI) or CAR T therapi... | prweb.com/... |
| 09.06.2022 | Improving Clinical Research in Oncology Using Immune Scoring... | In this promising race against cancer, biomarkers represent one of the cornerstones of drug developm... | prweb.com/... |
| 09.07.2021 | Veracyte Announces Key Appointments To Executive Leadership ... | Rob Brainin Named Executive Vice President and Chief Business Officer; Bill Zondler Appointed Senio... | aithority.... |
| 22.03.2021 | Veracyte Appoints Muna Bhanji to Its Board of Directors | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 22, 2021-- Veracyte, Inc. (Nasdaq: VCYT), a globa... | oaoa.com/n... |
| 15.03.2021 | Veracyte Completes Acquisition of Decipher Biosciences | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 15, 2021-- Veracyte, Inc. (Nasdaq: VCYT) today an... | oaoa.com/n... |
| 10.03.2021 | Veracyte Commends New USPSTF Lung Cancer Screening Guideline... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 10, 2021-- Veracyte, Inc. (Nasdaq: VCYT) today co... | oaoa.com/n... |
| 28.03.2016 | Veracyte nabs $45M from Visium Healthcare Partners to furthe... | The next step for the company is to focus on its Percepta Bronchial Genomic Classifier – this was pi... | medcitynew... |
| 30.10.2013 | Domain, Versant Portfolio Firm Veracyte Hits IPO Market ... | Southern California venture capital investors Domain Associates and Versant Venture saw a public exi... | socaltech.... |
| 23.09.2013 | Domain, Versant Portfolio Firm Plans IPO | Veracyte, a portfolio firm of two, Southern California venture capital investors--Domain Associates ... | socaltech.... |
Show more